交易 Supernus - SUPN CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.12 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Supernus Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Apr 23, 2024 | 29.91 | 0.61 | 2.08% | 29.30 | 30.16 | 29.30 |
Apr 22, 2024 | 29.67 | 1.06 | 3.70% | 28.61 | 30.23 | 28.61 |
Apr 19, 2024 | 29.37 | 0.74 | 2.58% | 28.63 | 29.48 | 28.58 |
Apr 18, 2024 | 28.83 | -0.02 | -0.07% | 28.85 | 29.39 | 28.55 |
Apr 17, 2024 | 28.96 | -0.43 | -1.46% | 29.39 | 30.00 | 28.85 |
Apr 16, 2024 | 29.40 | -0.30 | -1.01% | 29.70 | 30.29 | 29.30 |
Apr 15, 2024 | 29.95 | -0.05 | -0.17% | 30.00 | 30.45 | 29.63 |
Apr 12, 2024 | 30.20 | -1.22 | -3.88% | 31.42 | 31.69 | 30.01 |
Apr 11, 2024 | 31.96 | 0.16 | 0.50% | 31.80 | 32.51 | 31.58 |
Apr 10, 2024 | 31.76 | 0.85 | 2.75% | 30.91 | 31.87 | 30.26 |
Apr 9, 2024 | 31.69 | 0.78 | 2.52% | 30.91 | 32.30 | 30.59 |
Apr 8, 2024 | 31.40 | 0.91 | 2.98% | 30.49 | 32.97 | 30.49 |
Apr 5, 2024 | 33.52 | 0.56 | 1.70% | 32.96 | 33.54 | 32.96 |
Apr 4, 2024 | 33.17 | -0.90 | -2.64% | 34.07 | 34.40 | 33.03 |
Apr 3, 2024 | 33.79 | 1.04 | 3.18% | 32.75 | 34.01 | 32.70 |
Apr 2, 2024 | 33.11 | 0.04 | 0.12% | 33.07 | 33.50 | 32.65 |
Apr 1, 2024 | 33.48 | -0.49 | -1.44% | 33.97 | 33.97 | 33.05 |
Mar 28, 2024 | 34.04 | 0.33 | 0.98% | 33.71 | 34.31 | 33.34 |
Mar 27, 2024 | 33.68 | 1.46 | 4.53% | 32.22 | 33.78 | 32.21 |
Mar 26, 2024 | 32.44 | -0.27 | -0.83% | 32.71 | 33.35 | 32.24 |
Supernus Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Tuesday, May 7, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q1 2024 Supernus Pharmaceuticals Inc Earnings Release Q1 2024 Supernus Pharmaceuticals Inc Earnings ReleaseForecast(预报) -上一页 - |
Friday, June 14, 2024 | ||
时间(协调世界时) (UTC) 14:00 | 国家 US
| 事件 Supernus Pharmaceuticals Inc Annual Shareholders Meeting Supernus Pharmaceuticals Inc Annual Shareholders MeetingForecast(预报) -上一页 - |
Tuesday, August 6, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q2 2024 Supernus Pharmaceuticals Inc Earnings Release Q2 2024 Supernus Pharmaceuticals Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 667.238 | 579.775 | 520.397 | 392.755 | 408.897 |
收入 | 667.238 | 579.775 | 520.397 | 392.755 | 408.897 |
收入成本,共計 | 87.221 | 75.061 | 52.459 | 16.66 | 15.356 |
毛利 | 580.017 | 504.714 | 467.938 | 376.095 | 393.541 |
總營業費用 | 621.114 | 493.746 | 346.699 | 244.184 | 264.453 |
銷售/一般/行政費用,總計 | 377.221 | 282.459 | 192.277 | 158.425 | 159.888 |
研究與開發 | 74.552 | 90.467 | 75.961 | 69.099 | 89.209 |
異常費用(收入) | 22.3 | 8.4 | 0 | ||
營業收入 | 46.124 | 86.029 | 173.698 | 148.571 | 144.444 |
利息收入(費用),非經營淨值 | 17.035 | -9.127 | -0.731 | -1.084 | 0.003 |
其他,淨值 | -2.416 | -3.727 | -4.319 | -4.271 | |
稅前淨收入 | 60.743 | 73.175 | 168.648 | 147.487 | 140.176 |
稅後淨收入 | 60.711 | 53.424 | 126.95 | 113.056 | 110.993 |
未計算非常項目前的淨收益 | 60.711 | 53.424 | 126.95 | 113.056 | 110.993 |
淨收入 | 60.711 | 53.424 | 126.95 | 113.056 | 110.993 |
普通股股東可獲收益 (不含非經常性項目) | 60.711 | 53.424 | 126.95 | 113.056 | 110.993 |
普通股股東可獲收益 (含非經常性項目) | 60.711 | 53.424 | 126.95 | 113.056 | 110.993 |
攤薄淨收入 | 64.267 | 53.424 | 126.95 | 113.056 | 110.993 |
攤薄後加權平均股 | 61.6798 | 54.3567 | 53.6897 | 53.8167 | 54.0989 |
扣除特別項目的每股攤薄盈利 | 1.04195 | 0.98284 | 2.36451 | 2.10076 | 2.05167 |
每股正常攤薄盈利 | 1.04195 | 1.28236 | 2.48228 | 2.10076 | 2.05167 |
非常規項目總計 | |||||
攤薄調整 | 3.556 | ||||
Depreciation / Amortization | 82.63 | 29.989 | 15.702 | ||
Other Operating Expenses, Total | -0.51 | -6.53 | 1.9 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 135.563 | 153.764 | 167.328 | 177.353 | 170.051 |
收入 | 135.563 | 153.764 | 167.328 | 177.353 | 170.051 |
收入成本,共計 | 21.091 | 23.46 | 22.954 | 25.878 | 20.457 |
毛利 | 114.472 | 130.304 | 144.374 | 151.475 | 149.594 |
總營業費用 | 153.15 | 148.588 | 132.994 | 178.876 | 158.705 |
銷售/一般/行政費用,總計 | 86.782 | 85.597 | 73.972 | 112.314 | 100.476 |
研究與開發 | 24.379 | 21.212 | 17.774 | 19.554 | 16.385 |
Depreciation / Amortization | 20.108 | 19.966 | 20.698 | 20.644 | 20.644 |
Other Operating Expenses, Total | 0.79 | -1.647 | -2.404 | 0.486 | 0.743 |
營業收入 | -17.587 | 5.176 | 34.334 | -1.523 | 11.346 |
利息收入(費用),非經營淨值 | 0.705 | 4.158 | 1.234 | 1.645 | 0.613 |
其他,淨值 | -0.245 | -0.317 | -0.428 | -0.566 | -0.635 |
稅前淨收入 | -17.127 | 9.017 | 35.14 | -0.444 | 11.324 |
稅後淨收入 | -0.831 | 16.948 | 25.481 | 1.749 | 7.865 |
未計算非常項目前的淨收益 | -0.831 | 16.948 | 25.481 | 1.749 | 7.865 |
淨收入 | -0.831 | 16.948 | 25.481 | 1.749 | 7.865 |
普通股股東可獲收益 (不含非經常性項目) | -0.831 | 16.948 | 25.481 | 1.749 | 7.865 |
普通股股東可獲收益 (含非經常性項目) | -0.831 | 16.948 | 25.481 | 1.749 | 7.865 |
攤薄淨收入 | -0.831 | 16.948 | 29.037 | 1.749 | 7.865 |
攤薄後加權平均股 | 54.503 | 62.4542 | 62.0898 | 55.0348 | 61.3972 |
扣除特別項目的每股攤薄盈利 | -0.01525 | 0.27137 | 0.46766 | 0.03178 | 0.1281 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.01525 | 0.27137 | 0.46766 | 0.03178 | 0.1281 |
異常費用(收入) | |||||
攤薄調整 | 3.556 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 734.151 | 601.59 | 630.417 | 472.644 | 493.487 |
現金和短期投資 | 461.334 | 339.68 | 422.533 | 347.073 | 356.018 |
現金等價物 | 93.12 | 203.434 | 288.64 | 181.381 | 192.248 |
短期投資 | 368.214 | 136.246 | 133.893 | 165.692 | 163.77 |
應收賬款總額,淨額 | 165.497 | 148.932 | 140.877 | 87.332 | 102.922 |
應收賬款 - 貿易,淨額 | 165.497 | 148.932 | 140.877 | 87.332 | 102.922 |
總庫存 | 91.541 | 85.959 | 48.325 | 26.628 | 25.659 |
預付的費用 | 15.779 | 27.019 | 18.682 | 11.611 | 8.888 |
總資産 | 1702.51 | 1689.15 | 1504.1 | 1160.28 | 977.811 |
物業/廠房/設備,總計 - 淨額 | 44.077 | 52.32 | 58.055 | 38.347 | 4.095 |
物業/廠房/設備,總計 - 總額 | 57.126 | 68.774 | 75.095 | 51.046 | 15.314 |
累計折舊,總計 | -13.049 | -16.454 | -17.04 | -12.699 | -11.219 |
無形資産,淨額 | 702.463 | 784.693 | 364.342 | 24.84 | 31.368 |
長期投資 | 93.896 | 119.166 | 350.359 | 591.773 | 418.798 |
其他長期資産,總計 | 10.902 | 13.867 | 23.018 | 32.678 | 30.063 |
流動負債總額 | 687.958 | 315.379 | 245.108 | 160.587 | 161.353 |
應付賬款 | 10.543 | 9.331 | 6.147 | 10.141 | 3.195 |
預提費用 | 237.464 | 241.076 | 189.392 | 144.759 | 143.598 |
應付票據/短期債務 | 401.968 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 37.983 | 64.972 | 36.221 | 5.687 | 14.56 |
負債總額 | 816.304 | 873.301 | 759.244 | 564.854 | 524.788 |
長期債務總額 | 0 | 379.252 | 381.986 | 345.17 | 329.462 |
長期債務 | 0 | 379.252 | 361.751 | 345.17 | 329.462 |
其他負債,總計 | 78.537 | 93.315 | 96.935 | 59.097 | 33.973 |
總權益 | 886.204 | 815.851 | 744.858 | 595.428 | 453.023 |
普通股 | 0.054 | 0.053 | 0.053 | 0.053 | 0.052 |
額外實收資本 | 408.115 | 434.337 | 409.332 | 388.41 | 369.637 |
留存收益(累計赤字) | 481.245 | 379.922 | 326.498 | 199.548 | 86.492 |
其他權益,總計 | -3.21 | 1.539 | 8.975 | 7.417 | -3.158 |
總負債和股東權益 | 1702.51 | 1689.15 | 1504.1 | 1160.28 | 977.811 |
已發行普通股總數 | 54.2538 | 53.2561 | 52.8685 | 52.5334 | 52.3166 |
商譽,淨額 | 117.019 | 117.516 | 77.911 | ||
Payable/Accrued | 9.587 | ||||
長期債務的當前部分/資本租賃 | 0 | 3.761 | |||
資本租賃義務 | 0 | 20.235 | |||
遞延所得稅 | 49.809 | 85.355 | 35.215 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 449.36 | 423.538 | 883.34 | 734.151 | 663.886 |
現金和短期投資 | 200.189 | 151.656 | 228.568 | 461.334 | 391.789 |
現金等價物 | 94.985 | 24.706 | 58.442 | 93.12 | 111.492 |
短期投資 | 105.204 | 126.95 | 170.126 | 368.214 | 280.297 |
應收賬款總額,淨額 | 141.764 | 136.556 | 143.568 | 165.497 | 164.086 |
應收賬款 - 貿易,淨額 | 141.764 | 136.556 | 143.568 | 165.497 | 164.086 |
總庫存 | 83.48 | 90.56 | 91.147 | 91.541 | 83.165 |
預付的費用 | 23.927 | 44.766 | 16.299 | 15.779 | 24.846 |
總資産 | 1285.16 | 1293.1 | 1791.81 | 1702.51 | 1693.13 |
物業/廠房/設備,總計 - 淨額 | 43.144 | 43.331 | 44.633 | 44.077 | 45.535 |
物業/廠房/設備,總計 - 總額 | 58.06 | 57.632 | 58.317 | 57.126 | 58.473 |
累計折舊,總計 | -14.916 | -14.301 | -13.684 | -13.049 | -12.938 |
商譽,淨額 | 117.019 | 117.019 | 117.019 | 117.019 | 117.383 |
無形資産,淨額 | 641.147 | 662.389 | 682.497 | 702.463 | 722.761 |
長期投資 | 25.125 | 37.478 | 54.157 | 93.896 | 131.937 |
其他長期資産,總計 | 9.365 | 9.344 | 10.162 | 10.902 | 11.627 |
流動負債總額 | 287.534 | 252.59 | 731.545 | 687.958 | 725.987 |
應付賬款 | 7.841 | 4.4 | 11.544 | 10.543 | 16.015 |
預提費用 | 233.103 | 227.47 | 231.653 | 237.464 | 252.757 |
應付票據/短期債務 | 0 | 0 | 480.863 | 401.968 | 401.438 |
長期債務的當前部分/資本租賃 | |||||
其他流動負債,總計 | 46.59 | 20.72 | 7.485 | 37.983 | 55.777 |
負債總額 | 372.969 | 373.191 | 879.658 | 816.304 | 840.331 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | 0 | 0 | |||
資本租賃義務 | |||||
遞延所得稅 | 35.224 | 44.3 | 49.668 | 49.809 | 58.164 |
其他負債,總計 | 50.211 | 76.301 | 98.445 | 78.537 | 56.18 |
總權益 | 912.191 | 919.908 | 912.15 | 886.204 | 852.798 |
普通股 | 0.055 | 0.055 | 0.054 | 0.054 | 0.054 |
額外實收資本 | 431.956 | 424.266 | 416.232 | 408.115 | 401.026 |
留存收益(累計赤字) | 481.386 | 497.362 | 498.193 | 481.245 | 455.764 |
其他權益,總計 | -1.206 | -1.775 | -2.329 | -3.21 | -4.046 |
總負債和股東權益 | 1285.16 | 1293.1 | 1791.81 | 1702.51 | 1693.13 |
已發行普通股總數 | 54.6308 | 54.5929 | 54.4706 | 54.2538 | 54.0535 |
其他流動資産,總計 | 403.758 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 60.711 | 53.424 | 126.95 | 113.056 | 110.993 |
经营活动产生的现金 | 116.826 | 127.127 | 138.399 | 143.129 | 128.986 |
经营活动产生的现金 | 85.543 | 32.595 | 18.141 | 6.659 | 7.063 |
Deferred Taxes | -26.324 | -4.994 | 0.568 | -5.832 | -4.167 |
非现金物品 | 19.039 | 42.532 | 29.255 | 28.633 | 19.831 |
已付现金利息 | 2.516 | 2.516 | 2.516 | 2.516 | 1.342 |
营运资金的变化 | -22.143 | 3.57 | -36.515 | 0.613 | -4.734 |
投资活动产生的现金 | -216.663 | -81.913 | -34.699 | -157.924 | -413.48 |
资本支出 | -0.412 | -2.045 | -3.449 | -2.736 | -0.844 |
其他投资现金流量项目,总计 | -216.251 | -79.868 | -31.25 | -155.188 | -412.636 |
融资活动产生的现金 | -10.477 | -130.42 | 3.559 | 3.928 | 376.438 |
股票的发行(报废),净额 | 12.423 | 7.095 | 4.361 | 3.928 | 77.27 |
现金净变化 | -110.314 | -85.206 | 107.259 | -10.867 | 91.944 |
Cash Taxes Paid | 16.2 | 25.19 | 45.428 | 51.54 | 34.772 |
融资现金流项目 | -22.9 | 0 | 0 | -10.435 | |
债务的发行(退还),净额 | 0 | -137.515 | -0.802 | 0 | 309.603 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 16.948 | 60.711 | 35.23 | 33.481 | 25.616 |
Cash From Operating Activities | 49.126 | 116.826 | 89.262 | 75.421 | 4.302 |
Cash From Operating Activities | 20.601 | 85.543 | 64.694 | 42.919 | 21.362 |
Deferred Taxes | -0.435 | -26.324 | -18.564 | -16.057 | -13.011 |
Non-Cash Items | 6.594 | 19.039 | 12.979 | -4.337 | -10.048 |
Cash Taxes Paid | 0.203 | 16.2 | 14.558 | 8.543 | 0.478 |
Cash Interest Paid | 0 | 2.516 | 2.516 | 1.258 | 1.258 |
Changes in Working Capital | 5.418 | -22.143 | -5.077 | 19.415 | -19.617 |
Cash From Investing Activities | 239.78 | -216.663 | -167.898 | -85.666 | -69.987 |
Capital Expenditures | -0.278 | -0.412 | -0.422 | -0.275 | -0.851 |
Other Investing Cash Flow Items, Total | 240.058 | -216.251 | -167.476 | -85.391 | -69.136 |
Cash From Financing Activities | 80.174 | -10.477 | -13.306 | -19.761 | -22.034 |
Issuance (Retirement) of Stock, Net | 1.811 | 12.423 | 9.594 | 3.139 | 0.866 |
Net Change in Cash | 369.08 | -110.314 | -91.942 | -30.006 | -87.719 |
Issuance (Retirement) of Debt, Net | 78.363 | 0 | 0 | ||
Financing Cash Flow Items | 0 | -22.9 | -22.9 | -22.9 | -22.9 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Supernus Company profile
关于 Supernus
Supernus Pharmaceuticals, Inc.是一家生物制药公司。 该公司专注于开发和商业化治疗中枢神经系统(CNS)疾病的产品。 其多样化的神经科学组合包括治疗癫痫、偏头痛、帕金森病(PD)中的低流动性、颈椎病肌张力障碍和慢性咽喉炎。 其商业产品组合包括用于治疗癫痫的Trokendi XR(托吡酯)和Oxtellar XR(奥卡西平)。 其APOKYN(盐酸阿朴吗啡注射液)是一种适用于急性、间歇性治疗晚期帕金森病(PD)患者的运动障碍的产品。 其XADAGO(safinamide)是一种适用于帕金森病患者左旋多巴/卡比多巴的辅助治疗的产品。 其MYOBLOC(rimabotulinumtoxinB)是一种适用于治疗成人颈椎病肌张力障碍和咽喉肿痛的产品。 它的中枢神经系统候选产品管道包括SPN-812、SPN-817、SPN-820、SPN-830和MYOBLOC。
Industry: | Proprietary & Advanced Pharmaceuticals |
9715 Key West Avenue
ROCKVILLE
MARYLAND 20850
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球610,000万多名交易者的一份子,选择利用Capital.com进行交易吧。